Work

Pentostatin, Cyclophosphamide, and Rituximab (PCR) Has Comparable Activity but Appears To Be Better Tolerated Than Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Patients with Previously Treated Chronic Lymphocytic Leukemia.

Year: 2005

Type: article

Source: Blood

DOI: 10.1182/blood.v106.11.2127.2127

Authors: Nicole Lamanna, Matt Kalaycio, Peter Maslak, Mark L. Heaney, Renier Brentjens, Joseph Jurcic, Emily Biederman, Alison N. Gencarelli, Katherine S. Panageas, David A. Scheinberg, Mark A. Weiss

Institutions: Memorial Sloan Kettering Cancer Center, Cleveland Clinic

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2555868972

FWCI: 0.148

Cites:

Cited by: 1

Related to: 10